Pharmaceutical Commerce - March/April 2017

‘Future proof’ your implementation by adhering to industry standards

Addressing patient recruitment and retention issues is a natural role for CTEs

Management of controlled room-temperature shipments generates rising demand

Rising tide of specialties lifts most providers’ businesses

Despite the buzz around digital media channels, pharma continues to pour marketing dollars into television

GPhA rebrands and aligns more closely with biosimilars

The looming November 2017 deadline for US pharma serialization drives rapid implementation

Is the industry’s VAWD accreditation being used for unfair advantage?

Scott Gottlieb, a former FDA and CMS executive, brings an experienced hand

QuintilesIMS lawsuit is countered by Veeva’s, claiming antitrust and restraint of trade

Initial plans include having a ‘seat at the table’ in PBM formulary discussions

Rare-disease drug also garnered a valuable pediatric review voucher

Three levels of security will be on display at Interphex

IntrinsiQ Specialty Solutions and ION Solutions apply resources to the task

Benefits of automated validation for regulated industries

IPC and Pace Alliance will combine on April 1

More capacity for frozen and refrigerated pharmaceuticals

'Rebates do not raise drug prices, drug makers do,' says the PBM

Q4 2016 Stericycle ExpertSolutions index counts 83 incidents, highest since 2014